Measles infection


Key articles

McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Full text  Abstract

Reference articles

1. Cherry JD. Measles virus. In: Cherry JD, Demmler-Harrison GJ, Kaplan SL, et al, eds. Textbook of pediatric infectious diseases. 7th ed. Philadelphia, PA: Saunders; 2014:2373-94.

2. UK Health Security Agency. Measles: the green book, chapter 21. 2019 [internet publication]Full text

3. World Health Organization. Measles. Dec 2019 [internet publication].Full text

4. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year two-dose vaccination program. N Engl J Med. 1994;331:1397-402.Full text  Abstract

5. Patel MK, Goodson JL, Alexander JP Jr, et al. Progress Toward Regional Measles Elimination - Worldwide, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1700-1705.Full text  Abstract

6. Centers for Disease Control and Prevention. Measles cases and outbreaks. Mar 2022 [internet publication].Full text

7. World Health Organization. Europe observes a 4-fold increase in measles cases in 2017 compared to previous year. February 2018 [internet publication].Full text

8. World Health Organization. Measles in Europe: record number of both sick and immunized. February 2019 [internet publication].Full text

9. World Health Organization. European Region loses ground in effort to eliminate measles. Aug 2019 [internet publication].Full text

10. Dixon MG, Ferrari M, Antoni S, et al. Progress toward regional measles elimination - worldwide, 2000-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1563-9.Full text  Abstract

11. World Health Organization. Immunization, vaccines and biologicals: measles. November 2017 [internet publication].Full text

12. Strebel PM, Papania MJ, Dayan GH, et al. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia, PA: Elsevier; 2013:352-87.

13. Hethcote HW. Measles and rubella in the United States. Am J Epidemiol. 983 Jan;117(1):2-13. Abstract

14. McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Full text  Abstract

15. Di Pietrantonj C, Rivetti A, Marchione P, et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407.Full text  Abstract

16. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec. 2017 Apr 28;92(17):205-27.Full text  Abstract

17. Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022. Feb 2022 [internet publication]Full text

18. UK Health Security Agency. Complete routine immunisation schedule. Feb 2022 [internet publication].Full text

19. Skoff TH, Magill AJ. Chapter 4: travel-related infectious diseases- Measles (Rubeola). In: Brunette GW, Nemhauser JB, eds. CDC Yellow Book 2020: Health Information for International Travel. New York, NY: Oxford University Press; 2020.Full text

20. Hyle EP, Rao SR, Jentes ES, et al. Missed opportunities for measles, mumps, rubella vaccination among departing U.S. adult travelers receiving pretravel health consultations. Ann Intern Med. 2017 Jul 18;167(2):77-84. Abstract

21. Gastanaduy P, Haber P, Rota PA, et al. Measles. In: Hall E, Wodi AP, Hamborsky J, et al, eds. CDC Pink Book 2021: Epidemiology and vaccine-preventable diseases. 14th ed. Washington, D.C. Public Health Foundation, 2021Full text

22. American Academy of Pediatrics Committee on Infectious Diseases. Measles. In Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.Full text

23. Hambidge SJ, Newcomer SR, Narwaney KJ, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun;133(6):e1492-9.Full text  Abstract

24. Klein NP, Lewis E, Fireman B, et al. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb;135(2):e321-9.Full text  Abstract

25. Scott P, Moss WJ, Gilani Z, et al. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78.Full text  Abstract

26. Guerra FM, Crowcroft NS, Friedman L, et al. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. Vaccine. 2018 Feb 28;36(10):1248-1255. Abstract

27. Nic Lochlainn LM, de Gier B, van der Maas N, et al. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1235-1245.Full text  Abstract

28. Nic Lochlainn LM, de Gier B, van der Maas N, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1246-1254.Full text  Abstract

29. Centers for Disease Control and Prevention. General best practice guidelines for immunization. Mar 2022 [internet publication].Full text

30. Hviid A, Hansen JV, Frisch M, et al. Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Ann Intern Med. 2019 Mar 5 [Epub ahead of print]Full text  Abstract

31. Maglione MA, Das L, Raaen L, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics. 2014 Aug;134(2):325-37.Full text  Abstract

32. Helfand RF, Heath JL, Anderson LF, et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis. 1997 Jan;175(1):195-9. Abstract

33. Ratnam S, Tipples G, Head C, et al. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol. 2000 Jan;38(1):99-104.Full text  Abstract

34. Centers for Disease Control and Prevention. Specimen collection, storage, and shipment. Feb 2022 [internet publication].Full text

35. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. Lancet. 2009 Oct 17;374(9698):1339-50. Abstract

36. Chen RT, Clark TA, Halperin SA. The yin and yang of paracetamol and paediatric immunisations. Lancet. 2009 Oct 17;374(9698):1305-6. Abstract

37. World Health Organization. Weekly epidemiological record: measles and vitamin A. August 2009 [internet publication].Full text

38. Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017 Mar 11;3:CD008524.Full text  Abstract

39. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990 Jul 19;323(3):160-4. Abstract

40. Yang HM, Mao M, Wan C. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005;(4):CD001479.Full text  Abstract

41. Banks G, Fernandez H. Clinical use of ribavirin in measles: a summarized review. In Smith RA, Knight V, Smith JAD, eds. Clinical applications of ribavirin. New York, NY: Academic Press; 1984:203-9.

42. Ross LA, Kim KS, Mason WH, et al. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med. 1990 Mar;88(3):313-4. Abstract

43. Chen S, Wu T, Kong X, et al. Chinese medicinal herbs for measles. Cochrane Database Syst Rev. 2011;(11):CD005531.Full text  Abstract

44. Gadroen K, Dodd CN, Masclee GMC, et al. Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open. 2018 Nov 8;8(11):e021465.Full text  Abstract

45. Mina MJ, Kula T, Leng Y, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019 Nov 1;366(6465):599-606.Full text  Abstract

Use of this content is subject to our disclaimer